The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJudges Scientific Regulatory News (JDG)

Share Price Information for Judges Scientific (JDG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 11,200.00
Bid: 11,200.00
Ask: 11,550.00
Change: 0.00 (0.00%)
Spread: 350.00 (3.125%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 11,200.00
JDG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition of EWB Solutions Ltd

29 Nov 2016 07:00

RNS Number : 3603Q
Judges Scientific PLC
29 November 2016
 

Press Release

29th November 2016

 

Judges Scientific plc

 

("Judges Scientific", "Judges", the "Company" or the "Group")

 

Acquisition of EWB Solutions Ltd

 

Judges Scientific, a group involved in the buy and build of scientific instrument businesses, announces that it has today acquired 100% of the issued share capital of EWB Solutions Ltd ("EWB" or the "Acquisition"), a maker of scientific devices based in Hemel Hempstead, Hertfordshire. EWB manufactures edge-welded bellows used in Ultra High Vacuum ("UHV") systems and various other applications. The Board expects the Acquisition to be immediately earnings enhancing.

The purchase price of EWB amounted to £1.76 million in cash. An additional payment will be made to reflect any excess working capital over and above the ongoing requirements of the business. The Board expects such payment to be covered by the cash inherited at the completion date.

Information on EWB

EWB specialises in the design and manufacture of edge-welded bellows. The product is constructed from a series of metal diaphragms, welded to form an accordion like structure that permits free movement between two environments whilst maintaining hermetic separation.

The majority of EWB's products are bespoke and sold directly to original equipment manufacturers ("OEMs") for integration into UHV systems; these provide high tech surface analysis & processing techniques, for use in semi-conductor manufacturing, nano-technology, nuclear science & general research. Other applications include aerospace, medical and industrial devices. Because of the OEM business bias, 85% of sales are within the UK but a significant proportion of EWB products used in system integration are built for export.

EWB was established in 1999 by Peter Moody, Steve Edwards and Bryan Walker, all of whom will continue in their present positions for at least six months to facilitate a smooth transition and may stay for up to two years or more according to their individual choice.

EWB's accounts for the financial year to 30 April 2016 show revenues of £1.2 million and pre-tax profits of £0.5 million. Net tangible assets amounted to £1.6million, including cash of £1.6 million.

EWB's operating profits for the year ended 30 April 2016, adjusted to eliminate non-recurring items and to reflect EWB's ongoing cost base within Judges, would have totalled £0.5m.

The average adjusted EBIT generated by EWB for the five years ended on 30 April 2016 was £0.44 million.

 

Financing of the Acquisition

The consideration for the Acquisition and associated transaction costs have been largely drawn down from the Group's £10 million acquisition facility granted in 2014 by Lloyds Bank Corporate Markets.

The Board believes that EWB is a solid and profitable company making quality products, which will consolidate the Group's pre-eminent position in the UHV field.

 

Alex Hambro, Chairman of Judges, said:

"EWB is an excellent company with quality products which will consolidate our Group's pre-eminent position in the Ultra High Vacuum field. This cash generative acquisition enhances our earnings and fits within the Judges growth model. We are delighted to welcome Peter, Steve, Bryan and their colleagues to Judges' team."

 

For further information please contact:

Judges Scientific

 

 

David Cicurel, CEO

Brad Ormsby, Group FD

Tel: +44 (0) 203 829 6970

 

Shore Capital (Nominated Adviser & Broker)

 

Stephane Auton

Edward Mansfield

Tel: +44 (0) 20 7408 4090

Media enquiries:

Abchurch (Financial Public Relations)

 

Julian Bosdet/George Robinson / Rebecca Clube

 

Tel: +44 (0) 20 7398 7741

www.abchurch-group.com

 

 

Notes to editors:

Judges Scientific plc (AIM: JDG), is a group involved in the buy and build of scientific instrument businesses. The Group currently consists of 15 businesses acquired since it was first admitted to AIM in 2003.

The acquired companies are primarily UK-based with products sold worldwide to a diverse range of markets including: higher education institutions, the scientific communities, manufacturers and regulatory authorities. The UK is a recognised centre of excellence for scientific instruments. The Group companies hold five Queen's Awards for innovation and export.

Judges Scientific maintains a policy of selectively acquiring businesses that generate sustainable profits and cash. Shareholder returns are created through the repayment of debt, organic growth and dividends.

The Group's companies predominantly operate in niche end markets, with long term growth fundamentals and resilient margins.

For further information, please visit www.judges.uk.com

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQAKFDDKBDBDDB
Date   Source Headline
3rd Apr 20237:01 amRNSAcquisition of Henniker Scientific Limited
3rd Apr 20237:00 amRNSAppointment of Joint Broker
31st Mar 20238:54 amRNSGrant of Options
22nd Mar 20237:00 amRNSFinal Results
8th Mar 20232:39 pmRNSTotal Voting Rights
8th Mar 20237:00 amRNSDirector/PDMR Shareholding
13th Feb 20238:48 amRNSDirector/PDMR Shareholding
2nd Feb 20239:17 amRNSDirector/PDMR Shareholding
1st Feb 20237:00 amRNSExecutive Director and Board Appointment
1st Feb 20237:00 amRNSTotal Voting Rights
23rd Jan 202310:27 amRNSGrant of Options
19th Jan 20237:00 amRNSFull Year Trading Statement and Notice of Results
9th Jan 20237:00 amRNSDirector/PDMR Shareholding
3rd Jan 20231:03 pmRNSTotal Voting Rights
21st Dec 202210:51 amRNSBlock listing Interim Review
20th Dec 202211:53 amRNSDirector/PDMR Shareholding
12th Dec 20228:52 amRNSHolding(s) in Company
6th Dec 20222:34 pmRNSDirector/PDMR Shareholding
1st Dec 202210:01 amRNSTotal Voting Rights
30th Nov 20224:41 pmRNSSecond Price Monitoring Extn
30th Nov 20224:35 pmRNSPrice Monitoring Extension
17th Nov 20228:54 amRNSDirector/PDMR Shareholding
7th Nov 20225:14 pmRNSDirector/PDMR Shareholding
7th Oct 20227:00 amRNSDirector/PDMR Shareholding
4th Oct 20223:55 pmRNSDirector/PDMR Shareholding
3rd Oct 202210:01 amRNSTotal Voting Rights
23rd Sep 20223:44 pmRNSDirector/PDMR Shareholding
22nd Sep 20227:00 amRNSInterim Results
6th Sep 20222:51 pmRNSDirector/PDMR Shareholding
2nd Sep 20223:16 pmRNSTotal Voting Rights
9th Aug 20229:20 amRNSDirector/PDMR Shareholding
1st Aug 202211:07 amRNSTotal Voting Rights
27th Jul 20224:08 pmRNSDirector/PDMR Shareholding
25th Jul 20227:00 amRNSHalf Year Trading Update and Notice of Results
8th Jul 20228:12 amRNSDirector/PDMR Shareholding
1st Jul 20225:34 pmRNSTotal Voting Rights
29th Jun 202211:13 amRNSDirector/PDMR Shareholding
27th Jun 20227:00 amRNSAcquisition of minority shareholding in Bordeaux
21st Jun 20227:00 amRNSDirector/PDMR Shareholding
10th Jun 202211:43 amRNSBlocklisting Return
9th Jun 202212:11 pmRNSDirector/PDMR Shareholding
9th Jun 20227:36 amRNSIssue of Shares – Replacement
8th Jun 20223:52 pmRNSIssue of Ordinary Shares
6th Jun 20223:00 pmRNSPurchase of Ordinary Shares
1st Jun 202212:48 pmRNSTotal Voting Rights
27th May 20221:08 pmRNSAppointment of auditor
24th May 20222:12 pmRNSResult of AGM
23rd May 202211:05 amRNSSecond Price Monitoring Extn
23rd May 202211:00 amRNSPrice Monitoring Extension
23rd May 20227:00 amRNSAcquisition of Geotek and new banking facilities

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.